scholarly journals Brief Cognitive Behavioral Therapy for Insomnia in Parkinson's Disease: A Case Series Study

Author(s):  
Chihaya Osawa ◽  
Yuichi Kamei ◽  
Kentaro Nozaki ◽  
Yoshihiko Furusawa ◽  
Miho Murata

2017 ◽  
Vol 3 (1) ◽  
Author(s):  
Meghan Humbert ◽  
James Findley ◽  
Maria Hernandez-Con ◽  
Lana M. Chahine




2018 ◽  
Vol 47 ◽  
pp. 54-59 ◽  
Author(s):  
Vincenza Castronovo ◽  
Andrea Galbiati ◽  
Marco Sforza ◽  
Mattia Poletti ◽  
Laura Giarolli ◽  
...  


2019 ◽  
Vol 4 (1) ◽  
pp. 35-42
Author(s):  
Daniel Ruivo Marques ◽  
Ana Allen Gomes ◽  
Vanda Clemente ◽  
José Moutinho dos Santos ◽  
Isabel Catarina Duarte ◽  
...  


2021 ◽  
Vol 12 ◽  
Author(s):  
Fangyi Luo ◽  
Mengfei Ye ◽  
Tingting Lv ◽  
Baiqi Hu ◽  
Jiaqi Chen ◽  
...  

Objective: The aim of this study was to perform a quantitative analysis to evaluate the efficacy of cognitive behavioral therapy (CBT) on mood disorders, sleep, fatigue, and its impact on quality of life (QOL) in Parkinson's Disease (PD).Methods: We searched for randomized controlled trials in three electronic databases. Fourteen studies, including 507 patients with PD, met the inclusion criteria. We determined the pooled efficacy by standard mean differences and 95% confidence intervals, using I2 to reveal heterogeneity.Results: The result showed CBT had a significant effect on depression [−0.93 (95%CI, −1.19 to −0.67, P < 0.001)] and anxiety [−0.76 (95%CI, −0.97 to −0.55, P < 0.001)]. Moderate effect sizes were noted with sleep disorders [−0.45 (95% CI, −0.70 to −0.20, P = 0.0004)]. There was no evident impact of CBT on fatigue or QOL. We found an intervention period >8 weeks was advantageous compared with <8 weeks, and CBT implemented in non-group was more effective than in group. Between the delivery methods, no significant difference was found.Conclusion: We found that CBT in patients with PD was an efficacious therapy for some non-motor symptoms in PD, but not efficacious for fatigue and QOL. These results suggest that CBT results in significant improvement in PD and should be used as a conventional clinical intervention.



2021 ◽  
Vol 18 (2) ◽  
pp. 372-377
Author(s):  
Eloy Trillo Novo ◽  
Daniel López López ◽  
Carmen de Labra Pinedo ◽  
Marta Elena Losa Iglesias ◽  
Ricardo Becerro de Bengoa Vallejo ◽  
...  


2019 ◽  
Vol 34 (5) ◽  
pp. 722-729 ◽  
Author(s):  
Roseanne D. Dobkin ◽  
Sarah L. Mann ◽  
Alejandro Interian ◽  
Michael A. Gara ◽  
Matthew Menza


Sign in / Sign up

Export Citation Format

Share Document